Brookfield Corp’s Endava DAVA Stock Holding History

Brookfield Corp’s Portfolio DAVA Stock Details DAVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-22,924	Closed	-$1.75M	–	687
2022 Q4	$1.75M	Buy	+22,924	New	+$1.7M	0.01%	430

Other funds holding DAVA

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

GPGA

Grandeur Peak Global Advisors Salt Lake City, Utah $432M AUM 42.58% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

DDC

DF Dent & Co Baltimore, Maryland $5.27B AUM 7.89% 1-Year Est. Return

CDAM (UK) London, United Kingdom $387M AUM 4.05% 1-Year Est. Return

SCA

Southpoint Capital Advisors New York $4.4B AUM 49.36% 1-Year Est. Return

Ensign Peak Advisors Salt Lake City, Utah $60.8B AUM 42.06% 1-Year Est. Return

Brookfield Corp's DAVA Position: Q1 2023 in Review

Brookfield Corp sold out of Endava (DAVA) in Q1 2023, closing a stake of 22,924 shares — an estimated $1.75M sold.

Brookfield Corp first reported a position in DAVA in Q4 2022 and held it in 1 quarter. The position peaked at $1.75M in Q4 2022. 189 funds tracked by Wall St. Rank hold DAVA as of Q1 2023.

Brookfield Corp reported no remaining Endava position as of Q1 2023 after selling out during the quarter.
Brookfield Corp sold 22,924 Endava shares in Q1 2023, an estimated $1.75M.
Brookfield Corp first reported a position in Endava in Q4 2022 and held it in 1 quarter.
Brookfield Corp's Endava position peaked at $1.75M in Q4 2022.
189 funds tracked by Wall St. Rank held Endava as of Q1 2023.

Based on Brookfield Corp's 13F filing for Q1 2023, filed 15 May 2023.